Details for Patent: 3,681,500
✉ Email this page to a colleague
Summary for Patent: 3,681,500
| Title: | Spray compositions for treatment of obstructive disorders of the respiratory tract and methods therefor |
| Abstract: | Inhalation spray compositions for the treatment of obstructive disorders of the respiratory tract, comprising as an active ingredient a physiologically compatible quaternary salt of Nisopropyl-N-methyl-nortropine tropic acid ester, optionally in combination with a mucolytic and/or a bronchospasmolytic. |
| Inventor(s): | Karl Zeile, Werner Schulz, Rolf Banholzer, Helmut Wick |
| Assignee: | CH Boehringer Sohn AG and Co KG , Boehringer Ingelheim GmbH |
| Application Number: | US94951A |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 3,681,500
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 3,681,500
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| P 19 62 496.5 | Dec 12, 1969 | |
International Family Members for US Patent 3,681,500
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Belgium | 760251 | ⤷ Start Trial | |||
| Canada | 942671 | ⤷ Start Trial | |||
| Germany | 1962496 | ⤷ Start Trial | |||
| Spain | 386308 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
